Molecular basis of antigenic variation in infectious bursal disease virus.
Four antigenically different strains of infectious bursal disease virus (IBDV), characterized by their reactivities with a panel of neutralizing monoclonal antibodies (MAbs), were selected to determine the molecular basis of antigenic variation. The large genome segment A, encoding the structural proteins of the U.S. variants GLS, DS326, E/Del and the vaccine strain D78, was cloned and sequenced. Comparison of the deduced amino acid sequences of the U.S. variants with other IBDV strains showed that most of the amino acid substitutions occur in the central region between residues 212 to 332, especially in the two hydrophilic regions between residues 212 to 223 and residues 314 to 324 of VP2 protein. By comparing the amino acid sequences of these variant viruses and their reactivities with IBDV specific MAbs, the putative amino acids involved in the formation of virus-neutralizing epitopes were identified. Comparison of the D78 versus PBG98 sequence showed that Gln at position 249 (Gln249) appears to be critical in binding with MAb B69. Similarly, comparison of the U.S. variant sequences with other serotype 1 sequences showed unique substitution(s) at residue Glu321 in GLS, residues Ile286, Asp318, Glu323 in E/Del, and residues Glu311 and Gln320 in DS326, which could be potential residue(s) involved in the recognition of MAb57, MAb67, and MAb179 epitopes, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
Vakharia
V N
VN
Center for Agricultural Biotechnology of Maryland Biotechnology Institute, University of Maryland, College Park 20742.
He
J
J
Ahamed
B
B
Snyder
D B
DB
D000595:Amino Acid Sequence; D000940:Antigenic Variation / Q000235:genetics*; D007243:Infectious bursal disease virus / Q000235:genetics* / Q000276:immunology; D008969:Molecular Sequence Data; D010802:Phylogeny; D017386:Sequence Homology, Amino Acid; D013045:Species Specificity; D015678:Viral Structural Proteins / Q000737:chemistry / Q000235:genetics* / Q000276:immunology
D015678:Viral Structural Proteins